Recombinant expression of proteins in a disulfide-bridged, two-chain form

Details for Australian Patent Application No. 2006207726 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Specht, Volker

Agent Wrays

Pub. Number AU-B-2006207726

PCT Pub. Number WO2006/076902

Priority 10 2005 002 978.7 21.01.05 DE

Filing date 20 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 14 April 2011

International Classifications

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/076902 Priority application(s): WO2006/076902

14 January 2010 Assignment before Grant

  Biotecon Therapeutics GmbH The application has been assigned to Merz Pharma GmbH & Co. KGaA

14 April 2011 Application Accepted

  Published as AU-B-2006207726

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207741-Apparatus for stimulation and artificial insemination of animals

2006207719-Oxygen-producing respiratory protection device